Pottier R, Kennedy J C
Department of Chemistry and Chemical Engineering, Royal Military College of Canada, Kingston, Ontario.
J Photochem Photobiol B. 1990 Dec 1;8(1):1-16. doi: 10.1016/1011-1344(90)85183-w.
Photochemotherapeutic agents are photosensitizers that are selectively retained by neoplastic tissue. When tumor tissue containing these drugs is irradiated with visible electromagnetic radiation, the photosensitizing reaction may lead to tumor eradication, termed photodynamic therapy. Exogenous photosensitizers commonly used in clinical trials are mainly porphyrin derivatives. Phthalocyanines are currently being investigated as "second generation" photochemotherapeutic agents. The mechanism by which these photosensitizers are selectively retained in neoplastic tissue is unclear. This review examines the role of tissue and cellular pH as a factor in selective biodistribution. The pH values of normal and tumor tissue are summarized and the ionic species distribution diagram of porphyrins is presented. A two-fold mechanism of selective biodistribution is advanced, one involving normal tissue vs. tumor tissue selectivity, the other involving intracellular vs. intercellular distribution of sensitizer ionic species.
光化学治疗药物是被肿瘤组织选择性保留的光敏剂。当含有这些药物的肿瘤组织受到可见电磁辐射照射时,光敏反应可能导致肿瘤根除,这被称为光动力疗法。临床试验中常用的外源性光敏剂主要是卟啉衍生物。酞菁目前正作为“第二代”光化学治疗药物进行研究。这些光敏剂在肿瘤组织中被选择性保留的机制尚不清楚。这篇综述探讨了组织和细胞pH值作为选择性生物分布因素的作用。总结了正常组织和肿瘤组织的pH值,并给出了卟啉的离子种类分布图。提出了一种双重选择性生物分布机制,一种涉及正常组织与肿瘤组织的选择性,另一种涉及敏化剂离子种类在细胞内与细胞间的分布。